Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious respiratory diseases
Research
Shionogi offers $600M for Swiss biotech's antibiotic program
Shionogi and BioVersys will work together to develop new ansamycin candidates for nontuberculous mycobacteria infections.
Darren Incorvaia
Jul 2, 2025 1:00am
Moderna touts 3 phase 1 data sets to bolster early vax work
Mar 27, 2024 3:21pm
Novo Nordisk Foundation sets up $260M vaccine initiative
Dec 18, 2023 11:14am
Sanger Institute launches virus sequencing initiative
Jan 13, 2023 7:35am
Pfizer nabs RSV biotech ReViral in quick $525M bolt-on
Apr 7, 2022 8:27am
Ex-FDA interim head Giroir returns to biotech to make antivirals
Feb 11, 2022 10:00am
